Charles Schwab’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,322
| Closed | -$7.46K | – | 3665 |
|
|
2023
Q2 | $7.46K | Hold |
13,322
| – | – | ﹤0.01% | 3600 |
|
|
2023
Q1 | $15.2K | Hold |
13,322
| – | – | ﹤0.01% | 3526 |
|
|
2022
Q4 | $14.9K | Hold |
13,322
| – | – | ﹤0.01% | 3517 |
|
|
2022
Q3 | $28K | Sell |
13,322
-19,391
| -59% | -$40.8K | ﹤0.01% | 3450 |
|
|
2022
Q2 | $45K | Hold |
32,713
| – | – | ﹤0.01% | 3406 |
|
|
2022
Q1 | $56K | Buy |
+32,713
| New | +$56K | ﹤0.01% | 3514 |
|
|
2021
Q3 | – | Sell |
-61,991
| Closed | -$187K | – | 3557 |
|
|
2021
Q2 | $187K | Sell |
61,991
-23,870
| -28% | -$72K | ﹤0.01% | 3271 |
|
|
2021
Q1 | $280K | Buy |
85,861
+3,349
| +4% | +$10.9K | ﹤0.01% | 3262 |
|
|
2020
Q4 | $340K | Sell |
82,512
-12,465
| -13% | -$51.4K | ﹤0.01% | 3110 |
|
|
2020
Q3 | $514K | Buy |
94,977
+3,644
| +4% | +$19.7K | ﹤0.01% | 2871 |
|
|
2020
Q2 | $615K | Buy |
91,333
+26,181
| +40% | +$176K | ﹤0.01% | 2759 |
|
|
2020
Q1 | $208K | Buy |
65,152
+26,778
| +70% | +$85.5K | ﹤0.01% | 3005 |
|
|
2019
Q4 | $269K | Sell |
38,374
-2,788
| -7% | -$19.5K | ﹤0.01% | 2995 |
|
|
2019
Q3 | $159K | Buy |
41,162
+2,064
| +5% | +$7.97K | ﹤0.01% | 3065 |
|
|
2019
Q2 | $149K | Buy |
39,098
+392
| +1% | +$1.49K | ﹤0.01% | 3107 |
|
|
2019
Q1 | $140K | Buy |
38,706
+632
| +2% | +$2.29K | ﹤0.01% | 3064 |
|
|
2018
Q4 | $296K | Buy |
+38,074
| New | +$296K | ﹤0.01% | 2940 |
|